Bear extends bet against Savient

By optionMONSTER February 16, 2011, 01:45:23 PM EDT

Savient Pharmaceuticals has been drifting lower, and one trader is adjusting a bearish position.

optionMONSTER's Depth Charge tracking system detected the purchase of 13,013 March 9 puts for $0.33. An equal-sized block of February 10 puts was sold at the same time for $0.05 against open interest, which indicates that an existing position was rolled to the lower strike.

SVNT The trade cost the investor $0.28 and gives them an additional month of downside exposure. The drug developer cratered in October after announcing that it was unable to find a buyer. That followed a huge rally in September after the Food and Drug Administration approved its Krystexxa gout medicine.

SVNT is won 0.4 percent to $9.96 in afternoon trading. Despite the declines, the shares are showing some signs of bottoming around current levels. They also have a heavy short interest--more than 20 percent of the float as of mid-January--which could potentially draw buyers to the equity.

The put roll may have been the work of a shareholder who's using the options as protection on a long position in the name. It could also have been done by a speculative bear looking for another push to the downside.

Overall option volume in SVNT is 12 times greater than average today, with puts accounting for a bearish 97 percent of the total, according to the Depth Charge.

(Chart courtesy of tradeMONSTER)




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Options

Referenced Stocks: SVNT



Latest News Video



From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%